Pfizer discontinues development of ‘obesity drug taken twice a day’ due to side effects… stock price falls 5%
2023-12-02 05:20:27 American pharmaceutical company Pfizer has discontinued the development of an obesity treatment drug that requires taking two pills a day. Pfizer announced on the 1st (local time) that it was discontinuing the development of Danuglyprone, an obesity treatment drug taken twice a day, saying, “The rate of side effects and discontinuation of medication … Read more